* Neuropace Inc NPCE.OQ reported a quarterly adjusted loss
of 48 cents per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 34 cents per share.
* Revenue was $12.63 million; analysts expected $11.31
million.
* Neuropace Inc's reported EPS for the quarter was a loss of 48
cents.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* Neuropace Inc shares had fallen by 6.6% this quarter.
* The company reported a quarterly loss of $8.49 million.
* Wall Street's median 12-month price target for Neuropace Inc
is $28.00
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated August 12 at 11:16 p.m. All
figures in US dollars unless otherwise stated